Rieckmann P - Search Results

1

A quality network model for the daily care of multiple sclerosis.

Blumhardt LD, Vermeij BJ, Amato M, Andersen O, Edan G, Fernandez O, Filippi M, Haas J, Hommes OR, Rieckmann P. Blumhardt LD, et al. Among authors: rieckmann p. Mult Scler. 2000 Aug;6(4):231-6. doi: 10.1177/135245850000600404. Mult Scler. 2000. PMID: 10962543

2

Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Multiple Sclerosis Therapy Consensus Group (MSTCG); Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Multiple Sclerosis Therapy Consensus Group (MSTCG), et al. Among authors: rieckmann p. J Neurol. 2008 Oct;255(10):1449-63. doi: 10.1007/s00415-008-0061-1. Epub 2008 Oct 29. J Neurol. 2008. PMID: 19005625

3

Local pain during REBIF injection is not due to acidic pH.

Buttmann M, Goebeler M, Rieckmann P. Buttmann M, et al. Among authors: rieckmann p. J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):1078. doi: 10.1136/jnnp.2003.025114. J Neurol Neurosurg Psychiatry. 2004. PMID: 15201384 Free PMC article. No abstract available.

4

Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse.

Rieckmann P, Martin S, Weichselbraun I, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Lüer W, Helwig A, et al. Rieckmann P, et al. Neurology. 1994 Dec;44(12):2367-72. doi: 10.1212/wnl.44.12.2367. Neurology. 1994. PMID: 7527508 Clinical Trial.

5

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.

Metz I, Rieckmann P, Kallmann BA, Brück W. Metz I, et al. Among authors: rieckmann p. Acta Neuropathol Commun. 2016 Aug 8;4(1):81. doi: 10.1186/s40478-016-0352-1. Acta Neuropathol Commun. 2016. PMID: 27503238 Free PMC article. No abstract available.

6

Limited efficacy of pentoxifylline as anti-inflammatory agent in experimental pneumococcal meningitis.

Zysk G, Brück W, Fischer FR, Mäder M, Rieckmann P, Nau R. Zysk G, et al. Among authors: rieckmann p. Clin Exp Immunol. 1997 Mar;107(3):458-61. doi: 10.1046/j.1365-2249.1997.d01-949.x. Clin Exp Immunol. 1997. PMID: 9067517 Free article.

7

UM 9(5)h and UM 9(5)p, human and porcine noncoding transcripts with preferential expression in the cerebellum.

Michel U, Kallmann B, Rieckmann P, Isbrandt D. Michel U, et al. Among authors: rieckmann p. RNA. 2002 Dec;8(12):1538-47. RNA. 2002. PMID: 12515386 Free PMC article.

8

Introduction of the Watzmann Severity Scale: A sensorimotor approach to estimate the course of inpatient rehabilitation in multiple sclerosis.

Gulde P, Hermsdörfer J, Rieckmann P. Gulde P, et al. Among authors: rieckmann p. Mult Scler Relat Disord. 2021 Feb;48:102674. doi: 10.1016/j.msard.2020.102674. Epub 2020 Dec 10. Mult Scler Relat Disord. 2021. PMID: 33340928

9

Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells.

Rieckmann P, Michel U, Albrecht M, Brück W, Wöckel L, Felgenhauer K. Rieckmann P, et al. J Neuroimmunol. 1995 Jul;60(1-2):9-15. doi: 10.1016/0165-5728(95)00047-6. J Neuroimmunol. 1995. PMID: 7642752

10

Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system.

Rieckmann P, Michel U, Albrecht M, Brück W, Wöckel L, Felgenhauer K. Rieckmann P, et al. Neurosci Lett. 1995 Feb 15;186(1):61-4. doi: 10.1016/0304-3940(95)11282-2. Neurosci Lett. 1995. PMID: 7783951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters